Addison Capital CO Abb Vie Inc. Transaction History

Addison Capital CO

$238 Million
Q3 2024

A detailed history of Addison Capital CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Addison Capital CO holds 7,192 shares of ABBV stock, worth $1.27 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

7,192

Previous 8,242 12.74%

Holding current value

$1.27 Million

Previous $1.41 Million 0.5%

% of portfolio

0.6%

Previous 0.63%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$163.84 - $199.33 $172,032 - $209,296	-1,050 Reduced 12.74%	7,192 $1.42 Million
Q2 2024 Jul 25, 2024	SELL	$154.79 - $180.76 $12,537 - $14,641	-81 Reduced 0.97%	8,242 $1.41 Million
Q1 2024 May 07, 2024	BUY	$159.82 - $182.1 $46,028 - $52,444	288 Added 3.58%	8,323 $1.52 Million
Q4 2023 Feb 08, 2024	BUY	$137.6 - $154.97 $102,099 - $114,987	742 Added 10.17%	8,035 $1.25 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $21,107 - $24,434	-158 Reduced 2.12%	7,293 $1.09 Million
Q2 2023 Aug 18, 2023	SELL	$132.51 - $164.9 $29,417 - $36,607	-222 Reduced 2.89%	7,451 $1 Million
Q1 2023 Apr 13, 2023	SELL	$144.61 - $166.54 $3,759 - $4,330	-26 Reduced 0.34%	7,673 $1.22 Million
Q2 2022 Jul 11, 2022	SELL	$137.62 - $174.96 $62,066 - $78,906	-451 Reduced 5.53%	7,699 $1.18 Million
Q1 2022 Apr 11, 2022	BUY	$131.98 - $163.75 $143,858 - $178,487	1,090 Added 15.44%	8,150 $1.32 Million
Q4 2021 Jan 18, 2022	SELL	$107.43 - $135.93 $7,949 - $10,058	-74 Reduced 1.04%	7,060 $956,000
Q2 2021 Jul 16, 2021	BUY	$105.21 - $117.21 $100,896 - $112,404	959 Added 15.53%	7,134 $804,000
Q4 2020 Jan 12, 2021	SELL	$80.49 - $108.67 $965 - $1,304	-12 Reduced 0.19%	6,175 $662,000
Q3 2020 Oct 13, 2020	SELL	$85.91 - $100.83 $4,209 - $4,940	-49 Reduced 0.79%	6,187 $542,000
Q2 2020 Jul 16, 2020	BUY	$73.37 - $98.18 $457,535 - $612,250	6,236 New	6,236 $612,000

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Addison Capital CO, based on Form 13F filings with the SEC.

News

Stay updated on Addison Capital CO with notifications on news.

Account

Addison Capital CO Abb Vie Inc. Transaction History